Cart
sales@molnova.com
FGFR2-IN-2
CAS No. 2677709-81-6
FGFR2-IN-2( —— )
Catalog No. M35560 CAS No. 2677709-81-6
FGFR2-IN-2 is a specific FGFR2 inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used in the study of cancer and cardiovascular disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 105 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFGFR2-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionFGFR2-IN-2 is a specific FGFR2 inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used in the study of cancer and cardiovascular disease.
-
DescriptionFGFR2-IN-2 (Compound 38) is a selective FGFR2 inhibitor with IC50s of 389, 29, and 758 nM for FGFR1, FGFR2, and FGFR3, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2677709-81-6
-
Formula Weight370.45
-
Molecular FormulaC23H22N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (168.71 mM; Ultrasonic (<60°C)
-
SMILESOc1ccc(cc1)-c1ccc2c(n[nH]c2c1)-c1ccc(cc1)N1CCNCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lewis D Turner, et al. From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. J Med Chem. 2022 Jan 27;65(2):1481-1504.?
molnova catalog
related products
-
hnps-PLA Inhibitor
Hnps-PLA Inhibitor is an inhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).
-
FGF-401
FGF-401 (NVP-FGF401, Roblitinib, FGF401)?is a first-in-class, potent, highly selective FGFR4 inhibitor with IC50 of 1.1 nM.
-
AZD4547
A potent and selective inhibitor of FGFR1/2/3 with IC50s of 0.2/1.8/2.5 nM.
